![Charlotta Elisabet Gummeson](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Charlotta Elisabet Gummeson
Direttore/Membro del Consiglio presso Lumina Adhesives AB
Posizioni attive di Charlotta Elisabet Gummeson
Società | Posizione | Inizio | Fine |
---|---|---|---|
Lumina Adhesives AB
![]() Lumina Adhesives AB Industrial SpecialtiesProcess Industries Lumina Adhesives AB provides switchable medical adhesive. It develops a Lumina Film dressing which consists of a thin polyurethane membrane, coated with a layer of switchable acrylic adhesive. It offers medical dressing that lose adhesion when exposed to visible light. The firm's products are used on fragile surfaces, including skin. The company was founded by Stefan Karl Wilhelm Svahn and Daniel Jacobsson in 2008 and is headquartered in Gothenburg, Sweden. | Direttore/Membro del Consiglio | - | - |
Storia della carriera di Charlotta Elisabet Gummeson
Precedenti posizioni note di Charlotta Elisabet Gummeson
Società | Posizione | Inizio | Fine |
---|---|---|---|
Almi Invest Fond SI AB
![]() Almi Invest Fond SI AB Investment ManagersFinance Almi Invest Fond SI AB (Almi Invest Fond SI) is a venture capital subsidiary of Almi Företagspartner Väst AB founded in 1979. The firm is headquartered in Vastra Gotaland, Sweden. | Analista di Private Equity | 15/07/2014 | 01/12/2015 |
Tridentify AB
![]() Tridentify AB Electronic Equipment/InstrumentsElectronic Technology Tridentify AB provides monitoring and quality assurance of blood bags. It products include the Tracer, the Access Point, the Check-in Node, the Web Portal and the Reader. The company was founded in 2009 by Petra Lindberg and Magnus Gramming and is headquartered in Gothenburg, Sweden. | Direttore/Membro del Consiglio | - | - |
GSK PLC | Vendite & Marketing | - | - |
ASTELLAS PHARMA INC. | Corporate Officer/Principal | - | - |
Laccure AB
![]() Laccure AB Pharmaceuticals: GenericHealth Technology Laccure AB develops products for the treatment and prevention of bacterial vaginosis. It is a pharmaceutical company that offers non-prescription vaginal tablet for women. The firm's product is based on a proprietary substance that releases lactic acid over an extended period of time to decrease elevated vaginal potential of hydrogen. It engages in research, development, training, marketing, and sales in the field of skin care and hygiene activities. The company was founded by Olov Arvid Sterner in 2007 and is headquartered in Helsingborg, Sweden. | Direttore/Membro del Consiglio | - | - |
Arterion AB
![]() Arterion AB BiotechnologyHealth Technology Arterion AB is a holding company that manufactures biomaterials, including artificial blood vessels, consisting of microbial derived cellulose for revascularization of patients with cardiovascular diseases. It focuses on pure uncoated cellulose grafts as replacement of human vessels, primarily as bypass grafts. Its manufacturing method is based on a novel technology that controls the life conditions of the microbe Gluconacetobacter xylinus. Its use of microbial derived cellulose will allow clinicians to use artificial blood vessels as replacement for vessels with an internal diameter of less than five millimeters. The company was founded on January 4, 2007 and is headquartered in Gothenburg, Sweden. | Direttore/Membro del Consiglio | - | - |
Statistiche
Distribuzione geografica
Svezia | 6 |
Giappone | 2 |
Regno Unito | 2 |
Posizioni
Director/Board Member | 4 |
Private Equity Analyst | 1 |
Corporate Officer/Principal | 1 |
Settori
Health Technology | 5 |
Finance | 2 |
Process Industries | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 2 |
---|---|
ASTELLAS PHARMA INC. | Health Technology |
GSK PLC | Health Technology |
Aziende private | 5 |
---|---|
Arterion AB
![]() Arterion AB BiotechnologyHealth Technology Arterion AB is a holding company that manufactures biomaterials, including artificial blood vessels, consisting of microbial derived cellulose for revascularization of patients with cardiovascular diseases. It focuses on pure uncoated cellulose grafts as replacement of human vessels, primarily as bypass grafts. Its manufacturing method is based on a novel technology that controls the life conditions of the microbe Gluconacetobacter xylinus. Its use of microbial derived cellulose will allow clinicians to use artificial blood vessels as replacement for vessels with an internal diameter of less than five millimeters. The company was founded on January 4, 2007 and is headquartered in Gothenburg, Sweden. | Health Technology |
Almi Invest Fond SI AB
![]() Almi Invest Fond SI AB Investment ManagersFinance Almi Invest Fond SI AB (Almi Invest Fond SI) is a venture capital subsidiary of Almi Företagspartner Väst AB founded in 1979. The firm is headquartered in Vastra Gotaland, Sweden. | Finance |
Laccure AB
![]() Laccure AB Pharmaceuticals: GenericHealth Technology Laccure AB develops products for the treatment and prevention of bacterial vaginosis. It is a pharmaceutical company that offers non-prescription vaginal tablet for women. The firm's product is based on a proprietary substance that releases lactic acid over an extended period of time to decrease elevated vaginal potential of hydrogen. It engages in research, development, training, marketing, and sales in the field of skin care and hygiene activities. The company was founded by Olov Arvid Sterner in 2007 and is headquartered in Helsingborg, Sweden. | Health Technology |
Lumina Adhesives AB
![]() Lumina Adhesives AB Industrial SpecialtiesProcess Industries Lumina Adhesives AB provides switchable medical adhesive. It develops a Lumina Film dressing which consists of a thin polyurethane membrane, coated with a layer of switchable acrylic adhesive. It offers medical dressing that lose adhesion when exposed to visible light. The firm's products are used on fragile surfaces, including skin. The company was founded by Stefan Karl Wilhelm Svahn and Daniel Jacobsson in 2008 and is headquartered in Gothenburg, Sweden. | Process Industries |
Tridentify AB
![]() Tridentify AB Electronic Equipment/InstrumentsElectronic Technology Tridentify AB provides monitoring and quality assurance of blood bags. It products include the Tracer, the Access Point, the Check-in Node, the Web Portal and the Reader. The company was founded in 2009 by Petra Lindberg and Magnus Gramming and is headquartered in Gothenburg, Sweden. | Electronic Technology |